ADVERTISEMENT
How Ajanta Pharma Plans To Beat Its Africa Business Slump
The maker of the erectile dysfunction drug Kamagra expects growth in Asia, U.S. to make up for decline in Africa, its key market.
07 Mar 2019, 04:32 PM IST
Ajanta Pharma Ltd. expects growth in India, Asia and U.S. to make up for the loss in business in its key market of Africa, which contributes a quarter of its revenue.Its institutional, or tender, business in Africa—under which it makes drugs on contract for governments and other institutions—is expected to either remain flat or decline by about 10 percent in the next financial year, a spokesperson for the specialty pharmaceutical mak...
I’m already a Subscriber Sign In
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits
Choose a plan
Renews automatically. Cancel anytime.
As a Subscriber you get
Access to
Stories
Curated
Newsletters
20,000+
Research Reports
Priority Pass
to Special Events
Ad-Lite
Experience
Members-Only
Rewards
NDTV Profit
Exclusive Stories
Full Access to
NDTV Profit App
Access to
Stories
20,000+
Research Reports
Ad-Lite
Experience
NDTV Profit
Exclusive Stories
Curated
Newsletters
Priority Pass
to Special Events
Members-Only
Rewards
Full Access to
NDTV Profit App
Still Not convinced ? Know More
Get live Stock market updates, Business news, Today’s latest news, Trending stories, and Videos on NDTV Profit.
ADVERTISEMENT